Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.64M | 10.06M | 9.40M | 9.96M | -47.00M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 1.90K | 2.20K | 2.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.99M | -10.44M | -9.75M | -10.39M | 46.51M |
| Change in Net Operating Assets | -87.90K | 46.40K | -5.20K | 179.30K | 128.20K |
| Cash from Operations | -434.90K | -341.50K | -348.50K | -253.90K | -354.40K |
| Capital Expenditure | -- | -- | -- | -1.10K | -1.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -1.10K | -1.10K |
| Total Debt Issued | 0.00 | 0.00 | 200.00K | 200.00K | 200.00K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -200.00K | -200.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 684.70K | 684.70K | 684.70K | 684.70K | 90.00K |
| Cash from Financing | 507.20K | 507.20K | 657.10K | 509.40K | 69.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.20K | 165.60K | 308.50K | 254.30K | -286.50K |